Ability of the Short Physical Performance Battery Frailty Index to Predict Mortality and Hospital Readmission in Patients with Liver Cirrhosis
Table 1
Demographic, clinical, and laboratory data of the studied population.
Variables
N=145
Age (mean ± SD)
60 ± 7
Gender (N, %)
Male
75(51.7%)
Female
70(48.3%)
Body mass index (mean ± SD)
24.2 ± 3.4
CPT† score (mean ± SD)
10 ± 2
Class (A)
12(8.3%)
Class(B)
50(34.5%)
Class(C)
83(57.2%)
MELD‡ Score (mean ± SD)
16 ± 6
MELD > 20
15(10%)
MELD ≤ 20
130(90%)
Comorbidities (N,%)
Diabetes Mellitus
45(31%)
Hypertension
22(15.2%)
Hematemesis (N, %)
28(19.3%)
Hb# gm/dl (mean ± SD)
9.11 ± 1.71
Albumin gm/dl (mean ± SD)
2.4 ± 0.5
Creatinine mg/dl (mean ± SD)
1.4 ± 0.3
Total Bilirubin mg/dl (mean ± SD)
1.7 ± 0.9
ALT§ IU/L (mean ± SD)
51 ± 97
AST IU/L (mean ± SD)
92 ± 198
INR†† (mean ± SD)
1.61 ± 0.91
TSH IU/L (mean ± SD)
1.99 ± 1.3
CrP‡‡ (mg/dl)
22.6
Hand grip score
14.9 ± 5.6
Short Physical Performance Battery
6 ± 3
Hospital readmission (3 months)
63(43.4%)
Patient survival (3 months)
Survivors (N, %)
118(81.4%)
Non-survivors (N, %)
27(18.6%)
SD standard deviation: , †, ‡, §, II, , and #. †CPT: Child-Turcotte-Pugh; ‡MELD: model for end stage liver disease; §ALT: alanine transaminase; AST: aspartate transaminase; #Hb: hemoglobin; TSH: thyrotropin stimulating hormone; ††INR: international normalized ratio; ‡‡CrP: C reactive protein.
